These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 18431035)

  • 1. Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis.
    Suzuki A; Sekiguchi S; Asano S; Itoh M
    J Pharmacol Sci; 2008 Apr; 106(4):530-5. PubMed ID: 18431035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to manage postmenopausal osteoporosis?
    Body JJ
    Acta Clin Belg; 2011; 66(6):443-7. PubMed ID: 22338309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis screening and risk management.
    Wilkins CH
    Clin Interv Aging; 2007; 2(3):389-94. PubMed ID: 18044189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.
    Cesareo R; Iozzino M; Alva D; Napolitano C; De Rosa B; Contini S; Mallardo L; Lauria A; Reda G; Orsini A
    Minerva Endocrinol; 2007 Dec; 32(4):275-95. PubMed ID: 18091664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of osteoporosis treatment - a research update.
    Lippuner K
    Swiss Med Wkly; 2012; 142():w13624. PubMed ID: 22815185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis.
    Lyritis GP; Georgoulas T; Zafeiris CP
    Ann N Y Acad Sci; 2010 Sep; 1205():277-83. PubMed ID: 20840284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Absolute risk for fracture and WHO guideline. Pharmacological intervention to prevent osteoporotic fractures in the elderly].
    Hosoi T;
    Clin Calcium; 2007 Jul; 17(7):1098-104. PubMed ID: 17607078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of bone quality. Bone quality and osteoporosis treatment].
    Mashiba T
    Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontiers in vitamin D; basic research and clinical application. Eldecalcitol: the effect on bones and calcium metabolism].
    Endo I; Matsumoto T
    Clin Calcium; 2011 Nov; 21(11):103-10. PubMed ID: 22040826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTH analogues and osteoporotic fractures.
    Verhaar HJ; Lems WF
    Expert Opin Biol Ther; 2010 Sep; 10(9):1387-94. PubMed ID: 20629581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of osteoporosis medications on bone quality.
    Benhamou CL
    Joint Bone Spine; 2007 Jan; 74(1):39-47. PubMed ID: 17196423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present and future pharmacotherapy for osteoporosis.
    Doggrell SA
    Drugs Today (Barc); 2003 Aug; 39(8):633-57. PubMed ID: 14566385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic considerations on secondary osteoporosis caused by diabetes mellitus].
    Azuma K
    Clin Calcium; 2009 Sep; 19(9):1345-52. PubMed ID: 19721208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.
    MacLean C; Newberry S; Maglione M; McMahon M; Ranganath V; Suttorp M; Mojica W; Timmer M; Alexander A; McNamara M; Desai SB; Zhou A; Chen S; Carter J; Tringale C; Valentine D; Johnsen B; Grossman J
    Ann Intern Med; 2008 Feb; 148(3):197-213. PubMed ID: 18087050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options in osteoporosis.
    Dominguez LJ; Scalisi R; Barbagallo M
    Acta Biomed; 2010; 81 Suppl 1():55-65. PubMed ID: 20518192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
    Shiraki M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
    [No Abstract]   [Full Text] [Related]  

  • 19. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
    Lewiecki EM
    J Womens Health (Larchmt); 2009 Oct; 18(10):1615-26. PubMed ID: 19857095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of immobilization osteoporosis].
    Inoue D
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():514-9. PubMed ID: 18159714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.